Dr. Raffaele M. Corbisiero Sr., MD

Dr. Corbisiero practices at Emanate Health Foothill Presbyterian Hospital - Mammography in Glendora, California.

Dr. Corbisiero's NPI, 1730172453, was assigned on August 29, 2005. Dr. Corbisiero graduated from University of Montreal Faculty of Medicine in 1984. Dr. Corbisiero holds California license A48113.

Dr. Corbisiero's primary practice is Emanate Health Foothill Presbyterian Hospital - Mammography, at 250 S Grand Ave., Glendora, CA 91741. The practice phone is (626) 857-3118.

Dr. Corbisiero's primary practice is Emanate Health Foothill Presbyterian Hospital - Mammography in Glendora, California. Dr. Corbisiero is also affiliated with Emanate Health Foothill Presbyterian Hospital. Dmand AI also links Dr. Corbisiero to 2 more hospitals, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Corbisiero practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Corbisiero's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Corbisiero is board certified in surgery by the American Board of Surgery. Dr. Corbisiero is licensed in California.

Dmand AI lists abdominal adhesion surgery, abdominal hernia repair surgery, acute gallbladder or bile duct inflammation, appendectomy, cancerous skin growth removal, colon removal, esophagus, stomach, or upper small intestine surgery and gallbladder removal among the conditions Dr. Corbisiero treats.

CMS data shows 506 Medicare services from Dr. Corbisiero across 5 procedure codes in 2024, for 217 Medicare patients. Medicare paid $57,042 for them.

CMS counts 217 Medicare patients who saw Dr. Corbisiero in 2024. The largest group is 65 to 74, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 53% are also on Medicaid. Their average risk score is 2.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Corbisiero's median patient age at 59, with 57% women.

In 2024, Dr. Corbisiero wrote 122 Medicare Part D claims for 86 patients. 100% of them were for generic drugs. CMS names the drug for 83 of them, across 2 drugs with 11 or more claims each, at $440 in total drug cost. In 2023, CMS named 63 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 39 out of 100 for Dr. Corbisiero for performance year 2024, reported individually. Dr. Corbisiero accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of hernia repair - groin (open) by Dr. Corbisiero, more than 93% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Corbisiero. The most frequent topics are Carcinoembryonic Antigen, Indium Radioisotopes and Abdominal Neoplasms. Dr. Corbisiero's most frequent co-authors are Raffaele Corbisiero, MD, Dave M. Yamauchi, MD and Jose M. Esteban, MD.

CMS Open Payments shows 131 general payments to Dr. Corbisiero from 21 drug and device companies from 2016 to 2025. Education make up the largest share, 52% of the total. Intuitive Surgical, Inc. paid the most, $22,194.

Dr. Corbisiero graduated from University of Montreal Faculty of Medicine in 1984.

Dr. Corbisiero is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.